Leslie Shinobu, MD PhD

Affiliations: 
Neurology Massachusetts General Hospital and Harvard University, Boston, MA, United States 
Google:
"Leslie Shinobu"
Mean distance: 17.48 (cluster 28)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Fromer M, Roussos P, Sieberts SK, et al. (2016) Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nature Neuroscience
Dai Y, Zheng K, Clark J, et al. (2014) Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation. Human Molecular Genetics. 23: 637-47
Sakurai T, Shinobu LA, Sawa A. (2013) Schizophrenia research in 2013: are we making progress? Neurobiology of Disease. 53: 1-2
Cashman N, Tan LY, Krieger C, et al. (2008) Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle & Nerve. 37: 620-5
Liu J, Shinobu LA, Ward CM, et al. (2005) Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis. Journal of Neurochemistry. 93: 875-82
Hogarth P, Kayson E, Kieburtz K, et al. (2005) Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7
Eskandar EN, Flaherty A, Cosgrove GR, et al. (2003) Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. Journal of Neurosurgery. 99: 863-71
Eskandar EN, Cosgrove GR, Shinobu LA. (2001) Surgical treatment of Parkinson disease. Jama. 286: 3056-9
Counihan TJ, Shinobu LA, Eskandar EN, et al. (2001) Outcomes following staged bilateral pallidotomy in advanced Parkinson's disease. Neurology. 56: 799-802
Montine TJ, Shinobu L, Montine KS, et al. (2000) No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls. Annals of Neurology. 48: 950
See more...